12 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
, age, position and tenure of our Class I director who is up for re-election at the Annual Meeting for a term expiring at the 2026 Annual Meeting …
The following table sets forth the name, age, position, and tenure of the directors who are serving for terms that end following the Annual Meeting.
Name
10-K/A
2022 FY
COYA
Coya Therapeutics Inc
1 May 23
Annual report (amended)
5:12pm
chemistry groups throughout her tenure at Pfizer Inc. (NYSE:PFE)(“Pfizer”), Dr. Villalobos’ teams delivered more than 30 candidates which showed increased
424B4
COYA
Coya Therapeutics Inc
30 Dec 22
Prospectus supplement with pricing info
4:17pm
Chemistry. As the leader of several medicinal chemistry groups throughout her tenure at Pfizer Inc. (NYSE:PFE)(“Pfizer”), Dr. Villalobos’ teams delivered
S-1/A
5ggewn3x rer9x6uteo
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-3.3
rtvwbmsy
18 Nov 22
IPO registration
5:06pm
S-1
21irgn441 6w
18 Nov 22
IPO registration
5:06pm
DRS/A
EX-3
8w1fjfqg
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
odlq27
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
soem4u
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
xscc89
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next